David Peloquin Co-Authors Journal of Law, Medicine & Ethics Article on Assessing Federal Policies to Reduce Economic Barriers to Clinical Trial Enrollment

Health care partner David Peloquin co-authored an article in the Journal of Law, Medicine & Ethics discussing compensation to clinical trial participants and the extent to which it can cause study participants to lose access to means-tested programs by causing them to exceed the income limitations for such programs.

The authors note that low income can pose barriers to enrollment of Americans in clinical trials. To help achieve representative clinical trials for various disease conditions, the authors suggest that the U.S. Congress should consider passing legislation to exclude certain payments to clinical trial participants from gross income and expand the clinical trial compensation exclusions for means-tested programs established in the Ensuring Access to Clinical Trials Act of 2015.